PGP92
4466MW
Dr.Ranjith Kumar C R
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 4466MW | Dr.Ranjith Kumar C R | ranjithrp963@gmail.com | 9148049510 |
Medical Retina and Uvea
Beyond the Occlusion – Bevacizumab and Macular Recovery in BRVO.
Purpose : To evaluate the anatomical outcomes of intravitreal bevacizumab in patients with macular edema secondary to BRVO. Methods : Intravitreal bevacizumab (1.25 mg/0.05 mL) was given in the inferotemporal quadrant under aseptic precautions for 3 consecutive months. Post-injection, patients were followed up for 3 consecutive months. CMT (in µm) was measured using OCT at baseline and after intravitreal bevacizumab at 1 month, 2 months, and 3 months. Results: 12 patients were included in the study, which included 8 male patients and 4 female patients.Baseline mean CMT was 422 ± 32 µm before intravitreal bevacizumab injection. The mean CMT at 3 months was 288 ± 16 µm after 3 doses of intravitreal bevacizumab injection. Conclusion: Intravitreal bevacizumab provides significant anatomical and functional improvement in patients with macular edema secondary to BRVO, supporting its role as an effective treatment option.
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 4392 | Dr.Pawan Gampa Kumar | drpawangampa@gmail.com | 8861213079 |
| 4464MW | Dr.Sakshi gupta | gupta.sakshi161998@gmail.com | 9034237226 |